Match!
Ivana Babić
18Publications
4H-index
43Citations
Publications 19
Newest
#1Mirza Bojić (University of Zagreb)H-Index: 11
#2Zeljan Males (University of Zagreb)H-Index: 14
Last.Maja TomičićH-Index: 5
view all 5 authors...
Source
#1Ivana BabićH-Index: 4
#2Mirza Bojić (University of Zagreb)H-Index: 11
Last.Irena JukićH-Index: 6
view all 8 authors...
Source
Abstract Objectives The anti-HBc prevalence over a 14-years period (2004–2017), trends, infectivity, residual risk, and need for testing in blood donors (BD) of the Croatian Institute of Transfusion Medicine were assessed. Material and methods Anti-HBc was tested in 19,969 BD serum samples collected in 2004 (N = 7561), 2013 (N = 7318) and 2017 (N = 5090). All serums were initially screened for HBsAg, anti-HCV, HIV Ag/Ab, and anti-TP. 2013 and 2017 samples were also tested by ID-NAT. Results Over...
Source
#1Ivana BabićH-Index: 4
Last.Mirza BojićH-Index: 11
view all 6 authors...
#1Mirza BojićH-Index: 11
#2Željan MalešH-Index: 2
Last.Marica Medić-ŠarićH-Index: 16
view all 8 authors...
#1Ivana BabićH-Index: 4
Last.Mirza BojićH-Index: 11
view all 6 authors...
#1Ivana BabićH-Index: 4
#2Margareta MaslovicH-Index: 1
Last.Irena JukićH-Index: 6
view all 9 authors...
Source
Source
Croatia implemented individual donation (ID)-NAT testing of blood donors in 2013 for three viruses HBV, HCV, and HIV-1 as a mandatory test for all blood donors. This study assessed the impact of NAT screening 3 years after its implementation. A total of 545, 463 donations were collected and screened for HBV, HCV, and HIV-1 using the Procleix Ultrio Plus Assay. All initially reactive (IR) NAT samples were retested in triplicate and, if repeatedly reactive (RR), NAT discriminatory assay (dNAT) was...
4 CitationsSource
12